Progyny, Inc. Announces Details for Its Third Quarter 2024 Results Report
Progyny (Nasdaq: PGNY) has scheduled its Q3 2024 financial results announcement for Tuesday, November 12, 2024, after market close. The company will host a conference call at 4:45 P.M. ET, accessible to U.S. participants at 1.866.825.7331 and international participants at 1.973.413.6106 (passcode: 265484). An audio replay will be available through November 19, 2024. Progyny is a fertility, family building, and women's health benefits provider that offers comprehensive solutions including concierge support, coaching, and access to premier healthcare specialists.
Progyny (Nasdaq: PGNY) ha programmato l'annuncio dei risultati finanziari del terzo trimestre 2024 per martedì 12 novembre 2024, dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica alle 16:45 ET, accessibile ai partecipanti statunitensi al numero 1.866.825.7331 e ai partecipanti internazionali al numero 1.973.413.6106 (codice di accesso: 265484). Una registrazione audio sarà disponibile fino al 19 novembre 2024. Progyny è un fornitore di servizi di fertilità, costruzione della famiglia e benefici per la salute delle donne che offre soluzioni complete tra cui supporto personalizzato, coaching e accesso a specialisti sanitari di alto livello.
Progyny (Nasdaq: PGNY) ha programado el anuncio de sus resultados financieros del tercer trimestre de 2024 para el martes 12 de noviembre de 2024, después del cierre del mercado. La empresa llevará a cabo una conferencia telefónica a las 4:45 P.M. ET, accesible para participantes de EE.UU. en el número 1.866.825.7331 y para participantes internacionales en el número 1.973.413.6106 (código de acceso: 265484). Una grabación de audio estará disponible hasta el 19 de noviembre de 2024. Progyny es un proveedor de servicios de fertilidad, creación de familias y beneficios de salud para mujeres que ofrece soluciones integrales que incluyen apoyo personalizado, entrenamiento y acceso a especialistas en salud de primer nivel.
Progyny (Nasdaq: PGNY)는 2024년 3분기 재무 결과 발표를 2024년 11월 12일 화요일, 시장 종료 후로 예정했습니다. 이 회사는 오후 4시 45분 ET에 전화 회의를 개최할 예정이며, 미국 참가자는 1.866.825.7331, 국제 참가자는 1.973.413.6106으로 접속할 수 있습니다(비밀번호: 265484). 오디오 재청취는 2024년 11월 19일까지 가능합니다. Progyny는 생식, 가족 구성 및 여성 건강 혜택 제공자로, 맞춤 지원, 코칭 및 최고 의료 전문의에 대한 접근을 포함한 종합 솔루션을 제공합니다.
Progyny (Nasdaq: PGNY) a programmé l'annonce de ses résultats financiers du troisième trimestre 2024 pour le mardi 12 novembre 2024, après la fermeture du marché. L'entreprise organisera une conférence téléphonique à 16h45 ET, accessible aux participants américains au numéro 1.866.825.7331 et aux participants internationaux au numéro 1.973.413.6106 (code d'accès : 265484). Une rediffusion audio sera disponible jusqu'au 19 novembre 2024. Progyny est un fournisseur de services de fertilité, de constitution de famille et de prestations de santé pour les femmes, offrant des solutions complètes comprenant un support conciergerie, du coaching et un accès à des spécialistes de santé de premier plan.
Progyny (Nasdaq: PGNY) hat die Bekanntgabe der Finanzkennzahlen für das dritte Quartal 2024 auf Dienstag, den 12. November 2024, nach Börsenschluss terminiert. Das Unternehmen wird um 16:45 Uhr ET eine Telefonkonferenz durchführen, die für US-Teilnehmer unter 1.866.825.7331 und für internationale Teilnehmer unter 1.973.413.6106 (Zugangscode: 265484) zugänglich ist. Eine Audio-Wiedergabe wird bis zum 19. November 2024 verfügbar sein. Progyny ist ein Anbieter von Fruchtbarkeits-, Familienbildungs- und Gesundheitsleistungen für Frauen, der umfassende Lösungen einschließlich Concierge-Support, Coaching und Zugang zu führenden Gesundheitsdienstleistern bietet.
- None.
- None.
NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for the quarterly period ended September 30, 2024 after the close of the market on Tuesday, November 12, 2024.
The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call.
Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode.
An audio replay of the call will be available through Tuesday, November 19, 2024 and may be accessed by dialing 1.800.332.6854 (U.S. participants) or 1.973.528.0005 (international participants) with the passcode 265484.
A live webcast and archive of the call will be available from the Events and Presentations section of the Company’s website at http://investors.progyny.com.
About Progyny
Progyny (Nasdaq: PGNY) is a transformative fertility, family building and women’s health benefits solution, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients and physicians.
Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.
Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com
Media:
Alexis Ford
media@progyny.com
FAQ
When will Progyny (PGNY) release Q3 2024 earnings?
How can investors join Progyny's (PGNY) Q3 2024 earnings call?